Rx · PZN 02589439, 19874279
KADCYLA 160 mg powder for preparation of a concentrate for solution for infusion
German trade nameKADCYLA 160 mg Pulver zur Herstellung einer Infusions Lösungskonzentrat
Only sporadically available
2.6out of 10
Storage temperature and transport temperature
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for KADCYLA 160 mg powder for preparation of a concentrate for solution for infusion.
Review purchasing termsKADCYLA 160 mg powder for preparation of a concentrate for solution for infusion contains the active ingredient Trastuzumab emtansine (German Trastuzumab emtansin). 2 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 2.6 out of 10. The best-available pack was only sporadically available.
Pack sizes · 2 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 02589439 | 2.5 | 2.6 | ~ €2,457 |
| 19874279 | 0.0 | 0.0 | ~ €2,457 |
KADCYLA 160 mg powder for preparation of a concentrate for solution for infusion was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.
Request a source of supply